The DCCT/EDIC study, a large-scale clinical study on patients with type 1 diabetes, has clearly demonstrated that tight glycemic control through intensive insulin therapy significantly reduces the onset and progression of diabetic complications [1–4]. Here, INS is linked to type 1 diabetes mellitus.